Literature DB >> 16878197

Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma.

Antônio Marcos Raimondi1, Hélio Penna Guimarães, José Luiz Gomes do Amaral, Patrícia Helena Rocha Leal.   

Abstract

CONTEXT AND
OBJECTIVE: Preoperative glucocorticoid administration has been proposed for reducing postoperative morbidity. This is not widely used before esophageal resection because of incomplete knowledge regarding its effectiveness. The aim here was to assess the effects of preoperative glucocorticoid administration in adults undergoing esophageal resection for esophageal carcinoma. SEARCH STRATEGY: Studies were identified by searching the Cochrane Controlled Trials Register, MEDLINE, EMBASE, Cancer Lit, SCIELO and Cochrane Library, and by manual searching from relevant articles. The last search for clinical trials for this systematic review was performed in December 2004. SELECTION CRITERIA: This review included randomized studies of patients with potentially resectable carcinomas of the esophagus that compared preoperative glucocorticoid administration with placebo. DATA COLLECTION AND ANALYSIS: Data were extracted by the same reviewers, and the trial quality was assessed using Jadad scoring. Relative risk and weighted mean difference with 95% confidence limits were used to assess the significance of the difference between the treatment arms.
RESULTS: Four randomized trials involving 146 patients were found. There were no differences in postoperative mortality, sepsis, anastomotic leakage, hepatic and renal failure between the glucocorticoid and placebo groups. There were fewer postoperative respiratory complications (p = 0.005) and multiple postoperative complications (p = 0.004) and lower postoperative plasma interleukin-6 levels (p = 0.00001) with preoperative glucocorticoid administration. There was a higher postoperative PaO2/FiO2 ratio (p = 0.0001) with preoperative glucocorticoid administration.
CONCLUSION: Prophylactic administration of glucocorticoids is associated with decreased postoperative complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878197     DOI: 10.1590/s1516-31802006000200013

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  7 in total

1.  Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.

Authors:  Hiroya Takeuchi; Yoshiro Saikawa; Takashi Oyama; Soji Ozawa; Koichi Suda; Norihito Wada; Tsunehiro Takahashi; Rieko Nakamura; Naoyuki Shigematsu; Nobutoshi Ando; Masaki Kitajima; Yuko Kitagawa
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

2.  Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.

Authors:  Kazuhiko Mori; Kazuhiko Yamada; Takashi Fukuda; Takashi Mitsui; Takayuki Kitamura; Daisuke Yamaguchi; Jiro Ando; Ikuo Wada; Sachiyo Nomura; Nobuyuki Shimizu; Yasuyuki Seto
Journal:  Surg Today       Date:  2013-05-15       Impact factor: 2.549

3.  Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4.

Authors:  Klaus Buttenschoen; Marion E Schneider; Katja Utz; Marko Kornmann; Hans G Beger; Daniela Carli Buttenschoen
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

Review 4.  Regulating surgical oncotaxis to improve the outcomes in cancer patients.

Authors:  Toshihiro Hirai; Hideo Matsumoto; Hisako Kubota; Yoshiyuki Yamaguchi
Journal:  Surg Today       Date:  2013-06-05       Impact factor: 2.549

5.  Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus.

Authors:  Ruby M van Stein; Christianne A R Lok; Arend G J Aalbers; Ignace H J T de Hingh; Aletta P I Houwink; Herman J Stoevelaar; Gabe S Sonke; Willemien J van Driel
Journal:  Gynecol Oncol Rep       Date:  2022-02-26

6.  Development of Severe Hyponatremia due to Salt-Losing Nephropathy after Esophagectomy for Esophageal Cancer.

Authors:  Katsunobu Yoshioka; Minako Nishio; Soichi Sano; Katsunobu Sakurai; Keiko Yamagami; Yoshito Yamashita
Journal:  Case Rep Med       Date:  2009-10-28

7.  CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.

Authors:  Tomohiko Nishi; Hiroya Takeuchi; Sachiko Matsuda; Masaharu Ogura; Hirofumi Kawakubo; Kazumasa Fukuda; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Yoshiro Saikawa; Tai Omori; Yuko Kitagawa
Journal:  World J Surg Oncol       Date:  2015-08-01       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.